Clinical Trials Browser

Phase 1/2 × NETWORK × atezolizumab × Clear all

NCT04253145 2023-11-18

Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer.

Phase 1/2 Unknown

Small Cell Lung Carcinoma